In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Related Posts
VYNE Ends Phase IIb Vitiligo Trial of Repibresib After Missing Primary Endpoint
Image Credit: © Axel Bueckert – stock.adobe.com Key takeaways Repibresib missed both primary and key secondary endpoints in Phase IIb,…
Roche’s Novel Dual GLP-1/GIP Receptor Agonist Produces Clinically Meaningful Weight Loss in Phase Ib Trial
Image credit: 9dreamstudio | stock.adobe.com Roche’s dual GLP-1/GIP receptor agonist CT-388 produced positive findings treating obesity and type 2 diabetes…
Results of Phase II Clinical Trial Show Promise for Potential Obesity Treatment
Image Credit: © putilov_denis – stock.adobe.com Viking Therapeutics has announced positive top-line results from its Phase II clinical trial of…